Screening for Liver Cancer: The Rush to Judgment
- 6 March 2012
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 156 (5) , 387-389
Abstract
In 2005, a professional society issued a level I recommendation to use ultrasonography to screen the 3 million Americans with cirrhosis for hepatocellular carcinoma (HCC) every 6 months. This designation was based on a large randomized trial from China that reported a reduction in HCC deaths from screening in carriers of hepatitis B surface antigen. However, besides the difference in population, this trial did not report all deaths, excluded patients after randomization, and would almost certainly have found no significant difference if the cluster randomization had been accounted for in the analysis. Misplaced confidence in the Chinese trial has led many writers to accept the effectiveness of HCC screening as proven, making it more difficult to conduct the high-quality randomized trials that are needed to ensure optimal patient care.Keywords
This publication has 20 references indexed in Scilit:
- Pseudodisease, the Next Great Epidemic in Coronary Atherosclerosis?Archives of internal medicine (1960), 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Feasibility of conducting a randomized control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed?Hepatology, 2010
- Knowledge of Hepatocellular Carcinoma Screening Guidelines and Clinical Practices Among GastroenterologistsDigestive Diseases and Sciences, 2010
- Use of Surveillance for Hepatocellular Carcinoma Among Patients With Cirrhosis in the United StatesHepatology, 2010
- Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community SettingDigestive Diseases and Sciences, 2009
- Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves OutcomeThe American Journal of Medicine, 2008
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Controversies concerning randomization and additivity in clinical trialsStatistics in Medicine, 2004
- Randomized controlled trial of screening for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2004